Indonesia approves first homegrown Covid-19 vaccine

Published September 30, 2022
<p>People wearing protective face masks enjoy a stroll along a skywalk bridge as the Omicron coronavirus variant continues to spread, in Jakarta, Indonesia, February 7. — Reuters</p>

People wearing protective face masks enjoy a stroll along a skywalk bridge as the Omicron coronavirus variant continues to spread, in Jakarta, Indonesia, February 7. — Reuters

Indonesia has approved its first locally developed Covid-19 vaccine for emergency use, the head of the country’s public health agency said on Friday, hailing it as a step toward “the nation’s independence in access to medicine”.

Jakarta has stressed the importance of developing national vaccines since the beginning of the pandemic but it currently relies on China’s Sinovac and the Western-made Moderna and Pfizer-BioNTech mRNA jabs.

The IndoVac jab, developed by state-owned pharmaceutical company Bio Farma and Texas-based Baylor College of Medicine, can now be used as a primary dose for an unvaccinated or partially vaccinated adult in the world’s fourth most-populous country.

“The development … of a domestic vaccine is a pride for us Indonesians as a foundation and as the first step to achieve the nation’s independence in access to medicine,” head of the national food and drugs agency (BPOM) Penny Lukito said at a press conference on Friday.

The medical chief said IndoVac had shown an efficacy rate of 92 per cent, while there were no reports of death linked to it in trials and reported side effects were “generally mild”.

A clinical study to use it as a booster jab is underway, Lukito said.

The agency also announced it had granted emergency use approval for an mRNA vaccine developed in China, becoming the first country to do so.

The inoculation developed by Walvax Biotechnology will be locally produced in Indonesia, the BPOM chief said.

The homegrown IndoVac jab has been granted a halal certificate, meaning it can be administered in line with Islam in Muslim-majority Indonesia.

Indonesia became the epicentre of Asia’s Covid-19 pandemic in July last year as the Delta variant swept through the country.

Daily cases declined significantly by the end of the year but the spread of Omicron brought confirmed cases back to 30,000 a day.

It has since seen another sharp fall in case numbers and eliminated quarantine requirements for vaccinated travellers.

In total, Southeast Asia’s largest economy has reported over 6.4 million confirmed cases with nearly 160,000 deaths.

Vaccination rollout has also been relatively slow compared to developed nations, with less than two-thirds of the population of 270m receiving two jabs.

Opinion

Editorial

1971 in retrospect
Updated 28 Nov, 2022

1971 in retrospect

The point of no return came when the military launched Operation Searchlight in March 1971.
Gender-based violence
28 Nov, 2022

Gender-based violence

IT is a war without boundaries and seemingly without end. A UN report on femicide released on Nov 25, the...
Battle against dacoits
28 Nov, 2022

Battle against dacoits

THE Punjab police is clearly fighting a formidable, and so far losing, battle against the criminal gangs based in ...
Policy rate hike
Updated 27 Nov, 2022

Policy rate hike

The decision to hike the policy rate by 100bps is a step in the right direction, even if intended to appease the IMF.
Vawda’s reprieve
27 Nov, 2022

Vawda’s reprieve

FAISAL Vawda should be relieved. After years of running from a reckoning for submitting a false declaration in his...
Gujarat’s ghosts
27 Nov, 2022

Gujarat’s ghosts

TWO decades have passed since the bloody Gujarat riots, one of the worst spasms of anti-Muslim violence witnessed in...